Clinical Trial Update: Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating combination chemotherapy for patients with hormone-refractory prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Amgen | Conditions: Pain, Prostate Cancer | Phase 2 | Status: UNKNOWN